References
- Oosterhuis HJ. Myasthenia gravis. Groningen, The Netherlands: Groningen Neurological Press, 1997
- Berrouschot J, Baumann I, Kalischew-ski P, et al. Therapy of myasthenic crisis. Crit Care Med 1997; 25(7): 1228–35
- Cohen M, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci 1981; 377: 670–7
- Thomas C, Mayer S, Gungor Y, et al. Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation. Neurology 1997; 48(5): 1253–60
- Mayer S. Intensive care of the myasthenic patient. Neurology 1997; 48(Suppl 5): 70–75S
- Fink ME. Treatment of the critically ill patient with myasthenia gravis. In: Ropper AH, ed. Neurological and neurosurgical intensive care. 3d ed. New York: Raven Press, 1993: 351–62
- Rieder P, Louis M, Jolliet P, et al. The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 1995; 21(8):663–8
- DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol 1992; 49(12):1259–61
- Mayer SA, Thomas CE. Therapy of myasthenic crisis. (Letter) Crit Care Med 1998; 26(6):1136–7
- Gajdos P, Chevret S, Bernard C, et al. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997; 41(6):789–96
- Sanders DB, Howard JF Jr. Disorders of neuromuscular transmission. In: Bradley WG, Daroff RB, Fenichel GM, eds. Neurology in clinical practice. 2d ed. Boston: Butterworth, 1996:1983–2001